AAA specialist Endologix raises $16.6m from private placement:
This article was originally published in Clinica
Executive Summary
Endologix, the Irvine, California manufacturer of the minimally invasive Powerlink stent graft system to treat abdominal aortic aneurysms (AAAs), has agreed a private placement to raise $16.6m. It intends to invest the funds in a wider roll-out of Powerlink, which it has begun to commercialise in selected hospitals. It will hire new sales reps and expand the marketing programme.